Amlogenyx Inc.

Chemical, biological, and biochemical preparations for use in gene delivery technology, namely, nucleic acids in the nature of coding and non-coding deoxyribonucleic acids, plasmids, vectors, promotors, enhancers and regulatory sequences, for medical purposes for use in vitro laboratory use; Chemical, biological, and biochemical preparations for use in gene delivery technology, namely, nucleic acids in the nature of coding and non-coding deoxyribonucleic acids, plasmids, vectors, promotors, enhancers and regulatory sequences, for scientific purposes for use in vitro laboratory use; chemical, biological, and biochemical preparations for use in the manufacture of pharmaceutical preparations

Pharmaceutical preparations for the treatment of neurological and genetic diseases and disorders; chemical, biological, and biochemical preparations for use in gene delivery technology for medical use, namely, nucleic acids in the nature of coding and noncoding deoxyribonucleic acids, plasmids, vectors, promotors, enhancers and regulatory sequences, for use in in vivo therapeutic use in gene therapy

Printed publications, namely, books, brochures, informational pamphlets, informational cards, and advertisements being signs and boards of paper in the field of neurological and genetic diseases and disorders

Education and training services, namely, seminars, providing non-downloadable webinars, and workshops for healthcare professionals, caregivers, patients, and providers in the field of neurological and genetic diseases and disorders; online journals, namely, blogs featuring information on neurological and genetic diseases and disorders

Pharmaceutical, scientific, and medical research and development in the field of gene therapy manufacturing technology; biomedical and scientific research in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic diseases and disorders, neurological diseases and disorders, gene therapy, and cell therapy; biomedical research in the field of gene therapy design and delivery; new product design services in the field of gene therapy; product development of biochemical assays; product development in the fields of genetic therapies and effectors to regulate, modulate, and characterize disease states; pharmaceutical research and development in the field of gene therapy; scientific research in the nature of conducting clinical trials for others in the field of gene therapy design and delivery; scientific and medical research, namely, compiling and sharing of patient data for research purposes in the field of neurological and genetic diseases and disorders; medical and scientific research information in the field of neurological and genetic diseases and disorders; providing medical research and scientific research information in the field of neurological and genetic diseases and disorders; providing medical research and scientific research information in the field of gene therapies

Providing medical services, namely, gene therapy medical services in the field of neurological and genetic diseases and disorders; medical consultations in the field of neurological and genetic diseases and disorders; healthcare services, namely, providing an online database of medical and healthcare information in the field of neurological and genetic diseases and disorders, and collecting data and information on neurological and genetic diseases and disorders for screening, diagnosis and treatment purposes; medical information services in the nature of providing a database in the field of neurological and genetic diseases and disorder information based on collected patient data and information all for treatment and diagnostic purposes